2022
DOI: 10.3389/fgene.2022.815210
|View full text |Cite
|
Sign up to set email alerts
|

Case Report: Biallelic Loss of Function ATM due to Pathogenic Synonymous and Novel Deep Intronic Variant c.1803-270T > G Identified by Genome Sequencing in a Child With Ataxia–Telangiectasia

Abstract: Ataxia–telangiectasia (AT) is a complex neurodegenerative disease with an increased risk for bone marrow failure and malignancy. AT is caused by biallelic loss of function variants in ATM, which encodes a phosphatidylinositol 3-kinase that responds to DNA damage. Herein, we report a child with progressive ataxia, chorea, and genome instability, highly suggestive of AT. The clinical ataxia gene panel identified a maternal heterozygous synonymous variant (NM_000051.3: c.2250G > A), previously described to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
5
1

Relationship

3
3

Authors

Journals

citations
Cited by 7 publications
(12 citation statements)
references
References 42 publications
0
12
0
Order By: Relevance
“…In our C OMB G ENE research study—approved by the Conjoint Health Research Ethics Board at the University of Calgary (REB19-0245)—where we also include patients with well-defined clinical diagnoses, yet no genetic variants in known genes ( Maroilley et al, 2022 ), we enrolled a female patient with a clear clinical diagnosis of TSC presenting with subependymal nodules and cortical tubers, refractory epilepsy and infantile spasms, bilateral astrocytic retinal hamartomas, multiple cardiac rhabdomyomas, bilateral renal angiomyolipmas, hypomelanotic macules, angiofibromas, and moderate to severe intellectual disability (non-verbal). She had additional clinical features not typical for TSC; specifically, hypotonia, short stature (third centile), and dysmorphic features.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…In our C OMB G ENE research study—approved by the Conjoint Health Research Ethics Board at the University of Calgary (REB19-0245)—where we also include patients with well-defined clinical diagnoses, yet no genetic variants in known genes ( Maroilley et al, 2022 ), we enrolled a female patient with a clear clinical diagnosis of TSC presenting with subependymal nodules and cortical tubers, refractory epilepsy and infantile spasms, bilateral astrocytic retinal hamartomas, multiple cardiac rhabdomyomas, bilateral renal angiomyolipmas, hypomelanotic macules, angiofibromas, and moderate to severe intellectual disability (non-verbal). She had additional clinical features not typical for TSC; specifically, hypotonia, short stature (third centile), and dysmorphic features.…”
Section: Resultsmentioning
confidence: 99%
“…To further seek for the genetic origin of the condition, genome sequencing of the proband’s blood-derived DNA was performed using the Illumina TruSeq PCR-free DNA library and the Illumina NovaSeq 6000. Singleton srWGS was analysed as in Maroilley et al (2022 , 2023a) and as described in Methods. As no rare SNVs or indels were detected affecting the TSC1 or TSC2 , we expanded the gene-centric analyses to include more complex variants ( Maroilley et al, 2021 ; 2023a ; 2023b ).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The average depth of coverage achieved was 36 for individual II‐2 and 41 for II‐3. The data were analyzed to detect potentially causative single nucleotide variants (SNVs; as in Maroilley et al, 2022 11 ) and structural variants (SVs; based on a semi‐automated pipeline first developed using model organism genomes, and later adapted to human genomes 12 ). The ancestry of both individuals was assessed using the R package EthSeq 13 .…”
Section: Methodsmentioning
confidence: 99%